Article Details

PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in ...

Retrieved on: 2024-06-12 15:33:15

Tags for this article:

Click the tags to see associated articles and topics

PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in .... View article details on hiswai:

Excerpt

PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo